Target- |
MechanismMagnetic resonance imaging enhancers |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.SE |
First Approval Date06 Aug 2001 |
|
Mechanismfactor Xa inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.NL |
First Approval Date01 Jan 1991 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date09 Oct 1961 |
100 Clinical Results associated with neo CritiCare Pharma Co., Ltd.
0 Patents (Medical) associated with neo CritiCare Pharma Co., Ltd.
100 Deals associated with neo CritiCare Pharma Co., Ltd.
100 Translational Medicine associated with neo CritiCare Pharma Co., Ltd.